Prudent Man Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,045
Closed -$936K 134
2025
Q2
$936K Sell
5,045
-93
-2% -$17.3K 0.3% 80
2025
Q1
$1.08M Buy
5,138
+124
+2% +$24.1K 0.39% 56
2024
Q4
$891K Sell
5,014
-826
-14% -$152K 0.32% 72
2024
Q3
$1.15M Buy
5,840
+2,289
+64% +$427K 0.38% 63
2024
Q2
$609K Buy
3,551
+149
+4% +$24.7K 0.22% 106
2024
Q1
$620K Sell
3,402
-201
-6% -$34.6K 0.23% 105
2023
Q4
$558K Sell
3,603
-220
-6% -$32.1K 0.21% 108
2023
Q3
$570K Buy
3,823
+23
+0.6% +$3.38K 0.23% 104
2023
Q2
$512K Sell
3,800
-72
-2% -$10.6K 0.19% 111
2023
Q1
$617K Sell
3,872
-95
-2% -$14.5K 0.24% 98
2022
Q4
$641K Buy
3,967
+52
+1% +$7.97K 0.26% 96
2022
Q3
$525K Sell
3,915
-530
-12% -$76.1K 0.25% 89
2022
Q2
$681K Sell
4,445
-1,317
-23% -$201K 0.32% 59
2022
Q1
$934K Sell
5,762
-98
-2% -$14.2K 0.38% 51
2021
Q4
$793K Sell
5,860
-1,098
-16% -$130K 0.3% 60
2021
Q3
$751K Buy
6,958
+40
+0.6% +$4.57K 0.28% 75
2021
Q2
$779K Sell
6,918
-39
-0.6% -$4.39K 0.3% 66
2021
Q1
$753K Sell
6,957
-510
-7% -$54.6K 0.32% 67
2020
Q4
$800K Buy
7,467
+651
+10% +$62.6K 0.34% 58
2020
Q3
$597K Buy
6,816
+4,462
+190% +$420K 0.32% 69
2020
Q2
$231K Buy
+2,354
New +$207K 0.21% 128

Other funds holding ABBV

Prudent Man Advisors's ABBV Position: Q3 2025 in Review

Prudent Man Advisors sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 5,045 shares — an estimated $936K sold.

Prudent Man Advisors first reported a position in ABBV in Q2 2020 and held it in 21 quarters. The position peaked at $1.15M in Q3 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Prudent Man Advisors reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Prudent Man Advisors sold 5,045 AbbVie shares in Q3 2025, an estimated $936K.
  • Prudent Man Advisors first reported a position in AbbVie in Q2 2020 and held it in 21 quarters.
  • Prudent Man Advisors's AbbVie position peaked at $1.15M in Q3 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Prudent Man Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.